Due to a lack of controlled, prospective trials examining the pathophysiology and treatment
of catatonia, current guidelines vary regarding how and when to best use antipsychotics in …

3. Discussion The NMDA glutamate receptor is involved in synaptic plasticity and
neurotransmission [7]. By antagonizing NMDA receptors, ketamine increases glutamate …

Lurasidone is a second-generation antipsychotic agent approved for the treatment of
schizophrenia and bipolar disorders. 1, 2 Because of its favorable cardiometabolic profile, it …

Interventions: Treatment included administering a combination of esazolam injections and
olanzapine tablets, placing a gastric tube and urinary catheter, and providing nutritional …

Catatonia is an underrecognized disorder that has been widely described as a psychomotor
syndrome, with little emphasis on its thought and cognitive dimensions. The current …

Multiple authors have discussed challenges in diagnosis and management of catatonia, but
there are limited case studies highlighting multiple issues in both domains concurrently. We …

Introduction Catatonia is a syndrome characterized by psychomotor and behavioral
disturbances and is associated with a substantially increased mortality risk in adolescent …

Abstract MDMA (3, 4-methylenedioxy​ methamphetamine), also known as Ecstasy, is a
synthetic amphetamine with hallucinogenic and stimulant properties, which has become …

There is little research about the overlap and treatment of catatonia and delirium. Currently,
the DSM-5-TR does not acknowledge the potential overlap of these conditions in the clinical …

Neuroleptic malignant syndrome (NMS) is a potentially fatal side effect that occurs in
patients taking antipsychotics. Patients with NMS are often forced to rechallenge …